Avid Bioservices Inc (CDMO)

[pphmtoolong]

As one who has owned PPHM for a long time, it comes as no surprise that the share price bears little relationship to the progress Peregrine is making toward commercial success.

Peregrine has taken an obscure find from Dr. Thorpe's lab and built solid evidence that it can be a signicant treatment for the most common forms of cancer. Not only have they built evidence, they are months away from data in a pivotal, Phase III trial. By the way this trial was constructed in close collaboration with the FDA.

Also, Peregrine is making solid progress proving Bavi can amplify the results of big pharmas latest, greatest immune-oncology drugs.

Add the fact that little Avid continues to grow revenue at a healthy pace.

So, what does the share price do? Wanders around closer to $1 than $2. Some like to spin reasons why this makes sense. I don't buy their flimsy arguments, I buy PPHM shares.

IMO Bavi will soon prove it is a more valuable drug than the multi-billion dollar Avastin. When it does, nobody will care how many share are authorized, how much the BOD is paid, or who gets how many cheap options.

Some day, I hope soon, the share price will catch up with the reality.

GLTA, Especially Bavi-Arm Sunrise Patients,

Paul